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AbsTrACT
Introduction It is well established that physical activity 
(PA) protects against mortality and morbidity, but how 
long- term patterns of PA are associated with mortality 
and cardiovascular disease (CVD) remains unclear.
Methods 3231 men recruited to the British Regional 
Heart Study, a prospective cohort study, reported usual 
PA levels at baseline in 1978–1980 (aged 40–59 
years) and at 12- year, 16- year and 20- year follow ups. 
Twenty- year trajectories of PA, spanning from 1978/1980 
to 2000, were identified using group- based trajectory 
modelling. Men were subsequently followed up until 30 
June 2016 for mortality through National Health Service 
central registers and for non- fatal CVD events through 
primary and secondary care records. Data analyses were 
conducted in 2019.
results Three PA trajectories were identified: low/
decreasing (22.7%), light/stable (51.0%) and moderate/
increasing (26.3%). Over a median follow- up of 16.4 
years, there were 1735 deaths. Compared with the low/
decreasing group, membership of the light/stable (HR 
0.83, 95% CI 0.74 to 0.94) and moderate/increasing (HR 
0.76, 95% CI 0.66 to 0.88) groups was associated with 
a lower risk of all- cause mortality. Similar associations 
were observed for CVD mortality, major coronary heart 
disease and all CVD events. Associations were only 
partially explained by a range of confounders. Sensitivity 
analyses suggested that survival benefits were largely 
driven by most recent/current PA.
Conclusions A dose- response relationship was 
observed, with higher levels of PA from midlife to old age 
associated with additional benefits. However, even fairly 
modest and sustained PA was protective and may be 
more achievable for the most inactive.
InTroduCTIon
Physical activity (PA) is inversely associated with 
risk of all- cause mortality and cardiovascular disease 
(CVD) events in old age.1–4 Most of what is known 
about this relationship is based on studies using 
single measures of PA.5–8 However, major life tran-
sitions such as retirement are periods when PA may 
be sensitive to change.9–11 Previous studies suggest 
that initiation or maintenance of an active lifestyle 
can reduce mortality risks4 12–18 but the majority of 
these studies capture change across two time points 
only. Utilising additional repeated measures may 
give a more reliable estimate of the relationship 
between long- term PA and mortality.
Furthermore, conventional methods for defining 
PA changes are theory driven, which typically 
involves dividing subjects into clinically meaningful 
groups based on a relevant cut point (ie, maintainers, 
adopters, drop outs).19 20 However, this approach 
relies on the assumption that these patterns truly 
exist. By contrast, data- driven approaches, such as 
group- based trajectory modelling (GBTM), allow 
the most naturally occurring trajectories to emerge 
from the data rather than assuming predetermined 
trajectories.21 This method has been used to iden-
tify PA trajectories in older adults,22–25 but associ-
ations with subsequent mortality and CVD events 
have not been fully explored.
Two previous studies using GBTM suggested 
that more active trajectories are associated with 
a reduced risk of all- cause, cancer- related and 
CVD- related mortality.25 26 However, trajectories 
were either retrospectively reported26 or focused 
on a fairly short period of the adult life course.25 
These findings have yet to be replicated with longer 
prospective follow- up for PA, while also adjusting 
for established and novel CVD biomarkers. Associ-
ations with CVD subtypes also remain unclear. This 
study aimed to identify 20- year PA trajectories from 
midlife to old age using GBTM and to examine 
associations with subsequent major coronary heart 
disease (CHD) and stroke events and all- cause and 
CVD mortality.
MeThods
Participants
The British Regional Heart Study (BRHS) is a 
prospective cohort study involving 7735 men (aged 
40–59 years at baseline) recruited from primary 
care practices in 24 towns in Great Britain between 
1978 and 1980.27 Men completed a lifestyle and 
medical history questionnaire at baseline, 12- year, 
16- year and 20- year follow ups and attended 
physical examinations at baseline and the 20- year 
follow- up. Data collection spanned 1978–2016, 
and data were analysed in 2019.
Measurements
Pre-existing disease and CVd risk factors
At the 20- year follow- up, participants attending 
the physical examination provided a fasting blood 
sample, which was analysed for total, high- density 
lipoprotein (HDL) and low- density lipoprotein 
cholesterol (LDL), insulin, von Willebrand factor 
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(vWf), interleukin 6 (IL-6), n- terminal pro- brain natriuretic 
peptide (NT- proBNP) and high- sensitivity cardiac troponin T 
(Hs- TnT). Other physical measurements including waist circum-
ference, blood pressure and lung function (forced expiratory 
volume in one second (FEV1)) were taken by nurses. Information 
on measurement techniques are described in the supplementary 
files (online supplementary text A). Men also reported whether 
they had ever been diagnosed with a heart attack (coronary throm-
bosis or myocardial infarction (MI)), stroke or diabetes. Fasting 
blood glucose measures of ≥7 mmol/L confirmed diabetes diag-
nosis. Men also self- reported employment status (employed or 
not in employment); current or longest held occupation (manual 
or non- manual); marital status (single, married or widowed/
divorced); number of children (none or ≥1); doctor- diagnosed 
health conditions (arthritis, bronchitis and high blood pressure); 
other health problems (breathlessness and chest pain on exer-
tion); smoking status (current/recent ex- smoker or non- smokers/
long- term ex- smoker (>15 years)), alcohol consumption (none, 
occasional (<1 drink/week), light (1–15 drinks/week), moderate 
(16–42 drinks/week) or heavy (>42 drinks/week)); region of 
residence (Scotland, North, Midlands and South) and break-
fast cereal consumption (none, occasional (1–2 times/week) or 
regular (>3 times/week)). Baseline body mass index (BMI) was 
derived from height and weight measurements (normal weight: 
BMI <25.0 kg/m2 or overweight/obese: BMI ≥25.0 kg/m2).
self-reported PA
At baseline, 12- year, 16- year and 20- year follow ups, partici-
pants reported their usual PA, including time spent on all forms 
of walking, recreational activities (such as recreational walking, 
gardening, chores and do- it- yourself activities) and sport/exer-
cise. Questions and response options were virtually identical at 
each wave. Responses were scored based on the intensity and 
frequency of the activity.28 29 A total PA index was calculated 
by summing the scores for each item. The original scoring 
system has been reported elsewhere.30 The total PA index was 
then collapsed into a six- point score (0–5); inactive (0); occa-
sional (1) (regular walking or recreational activity only); light 
(2) (more- frequent recreational activities, sporting exercise less 
than once a week, or regular walking plus some recreational 
activity); moderate (3) (cycling, very frequent weekend recre-
ational activities plus regular walking, or sporting activity once 
a week); moderately vigorous (4) (sporting activity at least once 
a week or frequent cycling, plus frequent recreational activities 
or walking, or frequent sporting activities only); or vigorous (5) 
(very frequent sporting exercise or frequent sporting exercise 
plus other recreational activities). The PA score has been vali-
dated against heart rate, FEV1
30 and device- measured PA.31
Mortality and morbidity
Men were followed up for major CVD events and mortality 
from any cause from the 20- year follow- up in 2000 until 30 
June 2016. Information on cause of death was collected through 
the tagging procedures of the National Health Service Central 
Registers in Southport for England and Wales, and in Edinburgh 
for Scotland (death certificates coded using the International 
Classification of Diseases, Ninth Revision (ICD-9)). Informa-
tion on non- fatal events was obtained from general practitioners 
and biennial reviews of the patients’ medical records. For major 
CHD events (fatal/non- fatal), fatal MI was defined as ICD-9 
codes 410–414 and non- fatal MI was defined as heart attack or 
coronary thrombosis in accordance with the WHO diagnostic 
criteria. For major stoke events (fatal/non- fatal), fatal stroke was 
defined as ICD-9 codes 430–438 and non- fatal stroke events 
included those that caused a neurological deficit for >24 hours. 
Fatal CVD was defined as ICD-9 codes 390–459. Outcome 
measures included all- cause and CVD mortality, major CHD 
events (fatal/non- fatal), major stroke events (fatal/non- fatal) and 
all CVD events (fatal/non- fatal).
statistical analysis
Identifying PA trajectory groups
GBTM was used to identify 20- year PA trajectories over the four 
waves. Models were conducted using the Stata TRAJ plugin,32 
which applies finite mixture modelling and maximum like-
lihood estimation to identify latent groups of individuals that 
follow similar trajectories. Models with 2–5 trajectory groups 
were tested and compared using goodness- of- fit criteria. The 
best fitting model was determined based on the highest (ie, least 
negative) Bayesian information criterion, the log Bayes Factor 
(2*Δ Bayesian information criterion), trajectory group sizes of 
>5%, close agreement between estimated and actual trajectory 
group prevalence, posterior probabilities >0.70 and odds of 
correct classification based on posterior probabilities exceeding 
5.21 Subjects were assigned to the group that they had the highest 
probability of belonging to. Models simultaneously incorporated 
baseline predictors including age, occupational class, marital 
status, number of children, region of residence, diagnosed 
health conditions (arthritis, bronchitis and high blood pressure), 
BMI, smoking status, alcohol consumption and breakfast cereal 
consumption as well as time- varying variables, including number 
of CVD events and employment status. Trajectory shapes were 
determined by reducing the level of the polynomial function, 
starting with quadratic, until each growth parameter estimate 
was statistically significant (p<0.05). Descriptive statistics 
for demographic, lifestyle and CVD risk factors are presented 
according to trajectory groups.
survival analysis
Cox proportional hazards models were used to estimate asso-
ciations between trajectory groups and all- cause and CVD 
mortality, major CHD, stroke and all CVD events. For partici-
pants with no events, data were censored on the 30 June 2016. 
The proportional hazards assumption was examined using 
graphical methods and Schoenfeld residuals. Model 1 adjusted 
for age, marital status, alcohol consumption, smoking status and 
previous diagnosis of MI, stroke and diabetes (reported at the 
20- year follow- up), and occupational class and region (reported 
at baseline). To examine the role of potential mediators, model 2 
additionally adjusted for metabolic CVD risk factors measured at 
the 20- year follow- up, including LDL, HDL, systolic blood pres-
sure, insulin, waist circumference and FEV1. Model 3 addition-
ally adjusted for the inflammatory and haemostatic markers IL-6 
and vWf. Model 4 additionally adjusted for the cardiac markers 
Hs- TnT and NT- proBNP.
Additional analysis
As CVD events can influence PA and increase the risk of mortality, 
trajectories were also identified after excluding participants with 
CVD at the 20- year follow- up and associations with subsequent 
outcomes were estimated. Furthermore, as undiagnosed chronic 
conditions, such as CVD (eg, heart failure), may initiate changes 
in PA and increase the risk of mortality, analyses were performed 
after excluding the first 2 years of follow- up, thus minimising 
the possibility of reverse causation. As well as using GBTM to 
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Figure 1 Group- based trajectory modelling- derived physical activity 
trajectories and 95% CI from midlife to old age (n=3231).
Table 1 Subject characteristics at 20 year follow- up according to GBTM physical activity trajectories (n=3231)
Characteristic Low decreasing (n=733) Light stable (n=1649) Moderate increasing (n=849) All (n=3231)
Age, years (mean ± SD) 69.4 (5.6) 68.5 (5.6) 67.8 (5.1) 68.5 (5.5)
Manual occupation (%, n)* 59.8 (438) 55.6 (916) 38.5 (327) 52.0 (1681)
Alcohol consumption, ≥light† (%, n) 54.6 (400) 62.4 (1029) 73.5 (591) 63.5 (1178)
Current smoker (%, n) 19.5 (143) 10.6 (174) 7.4 (63) 11.8 (380)
Married (%, n) 80.5 (590) 85.0 (1402) 86.9 (738) 84.5 (2730)
Resident in southern England (%, n)* 26.2 (192) 36.2 (597) 38.2 (324) 34.5 (1113)
Waist circumference, cm (mean±SD) 100.1 (11.2) 96.4 (10.0) 95.4 (9.5) 97.0 (10.3)
LDL, mmol/L (mean±SD) 3.8 (1.0) 4.0 (1.0) 3.9 (0.9) 3.9 (1.0)
HDL, mmol/L (mean±SD) 1.3 (0.3) 1.3 (0.3) 1.4 (0.3) 1.3 (0.3)
Insulin, μ/mL (median, IQR) 9.6 (8.1) 8.1 (5.9) 7.5 (5.4) 8.2 (6.4)
SBP, mm Hg (mean±SD) 148.6 (23.9) 149.0 (23.8) 148.0 (24.4) 148.6 (24.0)
FEV1, L‡ (mean±SD) 235.2 (69.5) 259.6 (62.5) 276.1 (61.7) 258.4 (65.5)
IL-6, pg/mL (median, IQR) 2.8 (2.4) 2.2 (1.8) 2.0 (1.5) 2.2 (1.9)
vWf, IU/dL (mean±SD) 148.7 (48.4) 137.1 (45.0) 133.6 (43.0) 138.8 (45.6)
Hs- TnT, pg/mL (median, IQR) 12.7 (8.1) 11.4 (7.0) 11.5 (6.3) 11.7 (7.0)
NT- proBNP, pg/mL (median, IQR) 112.0 (206.0) 88.0 (136.0) 78.0 (111.0) 89.0 (144)
Previous MI (%, n) 9.1 (67) 7.3 (120) 6.0 (51) 7.4 (238)
Previous stroke (%, n) 3.3 (24) 2.4 (39) 2.2 (19) 2.5 (82)
Previous diabetes (%, n) 14.5 (106) 7.4 (122) 7.0 (59) 8.9 (287)
*Reported at baseline.
†light classified as ≥1 unit per week.
‡Standardised for height by multiplying FEV1 by the square of the mean population height (metres) divided by each participant’s height.
FEV1, forced expiratory volume in 1 s;GBTM, group- based trajectory modelling; HDL, high- density lipoprotein; Hs- TnT, high- sensitivity cardiac troponin T; IL-6, interleukin 6; LDL, low- density 
lipoprotein; MI, myocardial infarction; NT- proBNP, N- terminal pro- brain natriuretic peptide; SBP, systolic blood pressure; vWf, von Willebrand factor.
identify trajectories, we also grouped subjects based on observed 
trajectories using binary exposure measurements from baseline 
through 12- year and 20- year follow ups. The PA score was 
collapsed into a binary variable at each of the three time points, 
with 1 indicating at least ‘light’ PA levels and 0 denoting ‘inac-
tive’ or ‘occasional’ activity levels. This cut point has previously 
been used in studies using data from this cohort16 33 and was 
informed by a recent validation study, which highlighted a large 
increment in PA between those who are classified as ‘inactive’ 
or ‘occasionally active’ and other PA scores.31 There are eight 
possible trajectories indicated by combinations of zero and one. 
For example, (0-0-0) represents low PA at all periods, while 
(1-0-0) indicates high PA at baseline only. This approach for 
classifying trajectories can identify sensitive periods when expo-
sures during specific life stages might have a particularly strong 
effect on subsequent outcomes.34 Analyses were performed on 
selected outcomes with these alternate trajectory groupings.
resuLTs
From the 7735 men recruited at baseline, 5516 survived the next 
20 years of follow- up, of which 4252 attended the 20- year phys-
ical examination (77% of survivors). Of these, 197 men with 
<3 PA measures were excluded and a further 824 men were 
excluded due to missing covariate data, leaving 3231 available 
for analyses. Compared with the final sample, excluded men 
(n=4504) were significantly older at baseline (52.4 vs 48.7 
years; p<0.001), were more likely to be inactive (43.3% vs 
34.9%; p<0.001), come from manual occupations (66.3% vs 
52.0%; p<0.001) and suffer from a range of health conditions, 
including breathlessness (9.3% vs 2.8%; p<0.001), overweight/
obesity (55.3% vs 52.7%; p=0.020), arthritis (11.6% vs 8.1%; 
p<0.001) and bronchitis (20.8% vs 14.2%, p<0.001).
Three trajectory groups emerged as the most parsimonious 
description of the longitudinal data: low- decreasing (22.7%), 
light- stable (51.0%) and moderate- increasing (26.3%) (see 
figure 1). Results from the model selection process are provided 
in supplementary files, see online supplementary tables S1 and 
S2. A dose–response relationship was observed across trajectory 
groups, whereby men in the low- decreasing trajectory group were 
older, more likely to come from manual occupations, smoke, 
come from regions other than the south of England, suffer from 
a range of health conditions and have a worse cardiovascular risk 
profile (table 1).
Over a median follow- up of 16.4 years, there were 1735 
deaths. As shown in table 2, unadjusted mortality rates were 
lowest for the moderate- increasing trajectory group (30.9 per 
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1000 person- years) and highest for the low- decreasing group 
(58.8 per 1000 person- years). Compared with the low- decreasing 
group, membership of the light- stable and moderate- increasing 
trajectory groups was associated with a lower risk of all- cause 
mortality in minimally adjusted models. This association was 
somewhat attenuated after adjusting for cardiometabolic, 
inflammatory and cardiac biomarkers but remained statistically 
significant. There was a significant linear trend across trajec-
tory groups, suggesting added benefit for higher PA volumes. 
Similar patterns were observed for CVD events, CVD mortality 
and major CHD events, but trajectories were not associated with 
major stroke events. Additional analysis showed a significant risk 
reduction in fatal but not non- fatal stroke in men following a 
light- stable trajectory compared with the low- decreasing group 
(data not shown).
Additional analyses
In several models, the proportional hazards assumption was not 
met for age. Where violated, age was collapsed into 10 catego-
ries and centred. Models were run again with the categorised age 
variable, but no meaningful differences were observed (data not 
shown). All associations were similar after removing men with 
pre- existing CVD (see online supplementary table S3) and the 
first 2 years of follow- up (data not shown).
Observed trajectories based on binary exposure measurements
44% (n=1312) of men were classified as persistently active (1-1-
1), while membership of the other groups ranged from 5% to 
13%. Lower unadjusted mortality rates were observed for the 
more active trajectories (see online supplementary table S4). 
The highest unadjusted all- cause mortality rate was found in 
men who had become inactive at the 20- year follow- up (1-1-0) 
(55.7 per 1000 person- years) which was comparable with the 
persistently inactive group (0-0-0) (51.5 per 1000 person- years). 
Compared with men who were persistently inactive, trajectory 
groups containing men who were active at the 20- year follow- up 
with various combinations of activity/inactivity at previous time 
points were associated with a lower risk of all- cause mortality in 
minimally and fully adjusted models. Similar risk reductions were 
observed in those who became active by the 20- year follow- up 
(0-0-1) and those who were persistently active (1-1-1). Persistent 
activity (0-1-1 and 1-1-1) appeared to be important for CVD 
mortality and CVD events, but there was still weak evidence to 
suggest that becoming active (0-0-1) can protect against CVD 
mortality.
dIsCussIon
Patterns of PA from midlife to old age were associated with all- 
cause and CVD mortality and major CHD and CVD events but 
not major stroke events. A moderate- increasing pattern was asso-
ciated with the lowest risk of the aforementioned outcomes, but 
a light- stable pattern was also associated with significant benefit, 
which may be more achievable in the most inactive. Further-
more, adjustment for a range of confounders and mediating risk 
factors only partially explained these associations, suggesting 
that there may be other underlying biological pathways involved. 
For instance, physical activity may improve endothelial function 
and fibrinolytic activity; it may also have a direct effect on the 
cardiovascular system.35
It is well established that higher levels of PA are associated with 
a lower risk of mortality1–4 and our findings are consistent with 
this. Comparisons with previous studies investigating change in 
PA are not straightforward given the different methodologies 
used to identify trajectories. Studies reporting change across two 
time points suggest that initiating an active lifestyle can induce 
comparable survival benefits as those who are persistently 
active.4 14 16 18 36 Similarly, when using the observed trajectories 
based on binary exposure measurements, we found that current/
most recent PA was critical in the protection against mortality. 
Indeed, those classified with increasing PA (0-0-1) had a reduced 
mortality risk similar to those who were persistently active (1-1-
1). Although most survival benefits appear to be driven by most 
recent/current PA, engaging earlier in life is critical for contin-
uation in old age when the potential benefits come to fruition. 
Shifting inactive adults to achieve modest amounts of PA in 
midlife or earlier may lead to a carry- over effect resulting in 
ongoing PA and long- term survival benefits.
Using GBTM, we did not identify groups of older adults that 
made meaningful changes in PA, highlighting that adults shifting 
from low to even modest levels of PA are rare. Instead, the 
GBTM trajectories suggest that prior PA dictates PA in old age. 
This is consistent with some other GBTM studies using contin-
uous measures of PA that have also identified trajectories that do 
not typically overlap during this life period.25 37 38 In contrast, a 
recent study among retired adults using retrospectively reported 
PA showed that trajectories are more changeable across the life 
course than suggested by the present findings.26 Further research 
of this kind could help understand patterns of behaviour and 
inform interventions.
Studies using data- driven methods to identify PA trajectories 
and examine associations with subsequent mortality are scarce. 
One such study also identified three PA trajectories over a 7- year 
follow- up in an older sample.25 Similarly, these trajectories 
were largely determined by initial PA and the two most active 
trajectories were associated with a lower risk of all- cause and 
CVD mortality when compared with the least active. However, 
after adjusting for the final PA measure these associations were 
attenuated, suggesting that final PA was driving associations. 
The present study demonstrates similar findings but examines 
PA over a longer period and adjusts for a range of confounding 
and mediating factors. Notably, established risk factors only 
partially explained associations of PA trajectories with mortality 
and CVD. These associations also operated through inflamma-
tory, haemostatic and cardiac markers, which is consistent with 
other studies in middle- aged39–41 and older adults.20 Despite the 
observed associations of PA trajectories with all- cause mortality, 
CVD mortality, CHD events and all CVD events, no associations 
were observed with stroke events when fatal and non- fatal were 
combined. Evidence linking PA and stroke has been mixed42 and 
the optimal type and amount of PA remains unclear. This study 
was consistent with studies reporting no association between PA 
and major stroke events.43 44 This may be explained by the lack of 
association observed between trajectory groups and blood pres-
sure, which is an important risk factor for stroke, accounting for 
62% of stroke events.45 However, further exploratory analyses 
revealed a significant risk reduction for a light- stable trajectory 
when only fatal stroke was considered. This is in agreement with 
previous findings from the BRHS that showed similar associa-
tions with a single measure of walking time.46 Few studies inves-
tigating life course or change in PA have examined associations 
with CVD subtypes or differentiated between fatal and non- 
fatal stroke. One such study in a sample of Californian women 
showed that the inverse association observed between PA and 
risk of stroke was largely driven by fatal stroke events.47 Parallels 
can also be drawn between this finding and those of other obser-
vational studies that have shown that modest levels of PA may 
provide the greatest protection from stroke.43 47–49 Strengths of 
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this study include the prolonged follow- up, allowing the rela-
tionship between long- term PA trajectories and subsequent 
events to be examined. Other strengths include adjustment for 
a range of confounders and mediators and use of the same PA 
questionnaire at each wave. The GBTM approach allows the 
most naturally occurring trajectories to be identified, providing 
more accurate estimates of PA volume over time. An important 
limitation of this study is that subject attrition may have led to 
a biassed sample. The final sample was younger, healthier and 
more active than those who were excluded and may not be repre-
sentative of the general population. This also further restricted 
the sample size, which may not have been sufficiently powered 
to detect associations with outcomes that have few events, such 
as stroke. Although the PA score has been validated against heart 
rate, FEV1 and device- measured PA, self- reports may still be 
subject to recall and social desirability bias.31 While we control 
for a range of confounding factors, residual confounding may 
be present. Unmeasured health problems may lead to inac-
tivity and so the possibility of reverse causation remains, even 
after removing the first 2 years of follow- up. In addition, blood 
biomarkers are known to fluctuate, but they were measured at a 
single time point only. Furthermore, our sample comprises men, 
mainly of white British background and so our findings may not 
be generalisable to women and non- white ethnic groups.
ConCLusIon
During the transition to old age, PA trajectories were associ-
ated with all- cause and CVD mortality and major CHD and 
CVD events. A dose–response relationship was observed, with 
a moderate- increasing pattern of PA providing the most protec-
tion against mortality and CVD, but even a sustained light level 
of PA was beneficial and may be more feasible for inactive adults.
What is already known on this subject?
 ► Higher levels of physical activity (PA) are associated with a 
reduced risk of all- cause mortality and major cardiovascular 
disease events in old age.
 ► There is some evidence that long- term changes in PA 
during adulthood can impact the risks of mortality and 
cardiovascular disease (CVD), but the conventional 
approaches used to define how PA changes may be 
inadequate for describing the true patterns of PA over time.
What this study adds?
 ► Moderate increasing levels of PA from midlife to old age 
were associated with the lowest risk of major coronary heart 
disease events, CVD mortality and all- cause mortality in later 
life.
 ► However, a more modest level of PA that is sustained across 
adulthood may be sufficient to reduce the risk of these 
outcomes in later life.
 ► Promoting a light sustained level of PA across adulthood may 
be a feasible intervention target for the most inactive and 
provides similar benefits as greater volumes of PA across the 
adult life course.
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